These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
152 related items for PubMed ID: 9460702
1. Inhibitors of catecholamine metabolizing enzymes cause changes in S-adenosylmethionine and S-adenosylhomocysteine in the rat brain. Yassin MS, Cheng H, Ekblom J, Oreland L. Neurochem Int; 1998 Jan; 32(1):53-9. PubMed ID: 9460702 [Abstract] [Full Text] [Related]
7. Minor effect of tolcapone, a catechol-O-methyltransferase inhibitor, on extracellular dopamine levels modified by amphetamine or pargyline: a microdialysis study in anaesthetized rats. Tuomainen P, Törnwall M, Männistö PT. Pharmacol Toxicol; 1996 Jun; 78(6):392-6. PubMed ID: 8829199 [Abstract] [Full Text] [Related]
8. Studies on the tight-binding nature of tolcapone inhibition of soluble and membrane-bound rat brain catechol-O-methyltransferase. Borges N, Vieira-Coelho MA, Parada A, Soares-da-Silva P. J Pharmacol Exp Ther; 1997 Aug; 282(2):812-7. PubMed ID: 9262345 [Abstract] [Full Text] [Related]
18. Lack of an effect of Madopar on the disposition of tolcapone and its 3-O-methylated metabolite in rats. Funaki T, Onodera H, Ushiyama N, Tsukamoto Y, Tagami C, Fukazawa H, Kuruma I. J Pharm Pharmacol; 1995 Jun; 47(6):539-42. PubMed ID: 7674141 [Abstract] [Full Text] [Related]
20. The role of dopamine-metabolizing enzymes in the regulation of renal sodium excretion in the rat. Odlind C, Reenilä I, Männistö PT, Ekblom J, Hansell P. Pflugers Arch; 2001 Jul; 442(4):505-10. PubMed ID: 11510881 [Abstract] [Full Text] [Related] Page: [Next] [New Search]